GlyProVac
Pre-clinicalNovel BEMAP TechnologyStarting with E. coli-based infections like UTIs, GlyProVac’s BEMAP platform is an engine for creating novel bacterial vaccines.
Founded
2007
Focus
Vaccines
About
Novel BEMAP TechnologyStarting with E. coli-based infections like UTIs, GlyProVac’s BEMAP platform is an engine for creating novel bacterial vaccines.
Funding History
2Total raised: $4.3M
Grant$1.8MInnovation Fund DenmarkMar 15, 2022
Seed$2.5MNovo SeedsJun 15, 2021
Company Info
TypePrivate
Founded2007
LocationCopenhagen, Denmark
StagePre-clinical
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile